Lidocain is one of 198 small molecule programs targeting Neuropathic Pain. It is currently in Approved.
Indications
Total Trials
Active Trials
Competitors
Pipeline
Competition
357 competitors in Migraine
Lidocain
Aimovig
Vyepti
Bayer Aspirin
Savella
Cymbalta
Botox
Adempas
Viagra
Nitrostat
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Timeline
Clinical
Sources